News

Itsibio signs a distribution agreement with Biomedical Marketing Associates. BMA will market and distribute ITSI’s proteomics products including protein isolation, fractionation and assay kits in 5...

ITSI representative invited to speak at the International Symposium on Inflammation: An Underlying Factor in Several Diseases, Ibadan, Nigeria. A paper titled Role of Proteomics in Inflammation...

ITSIBIO today announced that instructors from AFDIL based in Rockville, MD have arrived Johnstown, PA to help train Nigerian Armed Forces DNA Bank (AFDB) personnel. The AFDIL team led by Michael D....

Itsibio and Lampire Biological Laboratories, Pipersville, PA sign a three year collaboration and teaming agreement covering antibody production, bioreagent development and proteomics.

ITSI representative invited to speak at the South African Bio2Biz International Biotechnology Conference, Durban, South Africa. A paper titled From Genomics and Proteomics to Bio-Business presented.

ITSIBIO today announced that 6 Nigerian AFDB personnel visited the United States Department of Defense (DoD) Armed Forces DNA Identification Laboratory...

Itsibio, Applied Isotope Technologies and MountainTop Technologies sign agreement to explore business opportunities of mutual interest involving proteomics.

Pennsylvania Governor Rendell announces the investment of $500,000 to enable ITSI to expand its research facility and operations.

ITSIBIO today announced that Nigerian Defence Headquarters Research and Development leaders, Major Gen BT Obasa (Chief, Research & Development) and Air Vice Marshall A Badeh (Director of...

Itsibio and Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil sign agreement to explore business opportunities of mutual interest involving...